Menu

Back to Medication Guide

Semaglutide

Generic Name: Semaglutide

Brand Names: Ozempic, Wegovy, Rybelsus

Semaglutide is used to treat type 2 diabetes and weight management. It is available as Ozempic, Wegovy, Rybelsus and is commonly prescribed in the diabetes category.

DiabetesGLP-1 AgonistsWeight Loss

Drug Class

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist

Pregnancy

Category C — Animal studies have shown adverse fetal effects including embryolethality, malformations, and growth alterations. There are no adequate well-controlled studies in pregnant women. Discontinue at least 2 months before a planned pregnancy because of the long half-life. Do not use during pregnancy.

Available Forms

Subcutaneous injection — Ozempic prefilled multi-dose pen (delivers 0.25 mg, 0.5 mg, 1 mg, or 2 mg per weekly dose), Subcutaneous injection — Wegovy prefilled single-dose pen (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg), Oral tablet — Rybelsus (3 mg, 7 mg, 14 mg)

What It's Used For

is prescribed to treat:

• Type 2 diabetes and weight management • Various related conditions in the diabetes category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

ConditionStarting DoseMaintenance Dose
Type 2 diabetes (Ozempic)0.25 mg SC once weekly for 4 weeksIncrease to 0.5 mg weekly; titrate to 1 mg or 2 mg weekly as needed for glycemic goals
Chronic weight management (Wegovy, BMI >= 30 or >= 27 with comorbidity)0.25 mg SC once weeklyEscalate every 4 weeks: 0.5 mg, then 1 mg, then 1.7 mg, then 2.4 mg weekly maintenance
Type 2 diabetes (Rybelsus, oral)3 mg PO once daily for 30 daysIncrease to 7 mg daily; may further increase to 14 mg daily after at least 30 days
Cardiovascular risk reduction (Wegovy, established CVD with overweight/obesity)0.25 mg SC once weeklySame titration to 2.4 mg weekly maintenance

Side Effects

Common side effects may include:

Nausea or stomach upset • Headache • Dizziness or lightheadedness • Fatigue or tiredness • Mild rash or itching

Serious side effects (seek immediate medical attention):

• Severe allergic reactions (rash, hives, swelling, difficulty breathing) • Unusual bleeding or bruising • Severe stomach pain • Signs of liver problems (yellowing of skin/eyes, dark urine) • Chest pain or irregular heartbeat • Severe dizziness or fainting • Signs of serious adverse effects

Drug Interactions

Semaglutide is not metabolized by CYP enzymes, so most interactions arise from delayed gastric emptying or additive glucose-lowering effects.

  • Insulin and sulfonylureas (e.g., glipizide, glimepiride): Substantially increased risk of hypoglycemia. Reduce the insulin or sulfonylurea dose — often by 20 percent or more — when initiating semaglutide, and monitor glucose closely.
  • Oral medications (Rybelsus interactions): Oral semaglutide must be taken first thing in the morning with no more than 4 ounces of water, on an empty stomach, and at least 30 minutes before any other oral medication, food, or beverage. Otherwise, absorption is markedly impaired.
  • Warfarin and other narrow-therapeutic-index oral drugs: Slowed gastric emptying may shift absorption profiles. Monitor INR closely after initiating or escalating semaglutide.
  • Levothyroxine: Reports of altered absorption with GLP-1 therapy. Maintain consistent timing relative to semaglutide and recheck TSH 6–8 weeks after starting.
  • Other GLP-1 receptor agonists or DPP-4 inhibitors (e.g., liraglutide, dulaglutide, sitagliptin): Concurrent use is not recommended due to overlapping mechanism, no incremental benefit, and additive GI side effects.
  • Alcohol: May worsen GLP-1 GI side effects and can independently raise hypoglycemia risk in patients also on insulin or sulfonylureas. Counsel moderation.

Additional Information

What is ?

Semaglutide (generic name: Semaglutide) is a medication primarily used to treat type 2 diabetes and weight management. It is marketed under the brand name(s) Ozempic, Wegovy, Rybelsus and belongs to the Diabetes category of medications.

How Does Semaglutide Work?

Semaglutide works through several mechanisms to provide therapeutic benefits:

  • Acts on specific receptors or pathways in the body
  • Modulates biological processes related to the treated condition
  • Provides symptom relief and improves quality of life
  • Helps manage the underlying condition effectively
  • Works best when combined with appropriate lifestyle modifications

The medication is designed to target the specific pathways involved in type 2 diabetes and weight management, making it an effective treatment option.

Common Uses

Primary Indications

Semaglutide is commonly prescribed for:

  • Type 2 diabetes and weight management: The main indication for this medication
  • Related Conditions: Associated symptoms and complications
  • Prevention: May help prevent progression of certain conditions
  • Symptom Management: Reduces discomfort and improves daily function

Additional Uses

In some cases, Semaglutide may also be prescribed for:

  • Off-label uses as determined by your healthcare provider
  • Combination therapy with other medications
  • Long-term management of chronic conditions
  • Short-term treatment of acute symptoms

Dosage and Administration

Semaglutide dosing varies based on the specific condition being treated and individual patient factors.

Typical Dosing:

  • Starting dose is typically determined by your healthcare provider
  • May be adjusted based on response and tolerability
  • Can be taken with or without food (follow specific instructions)
  • Usually taken once or twice daily

Administration Tips:

  • Take at the same time(s) each day for best results
  • Swallow tablets/capsules whole unless instructed otherwise
  • Don't skip doses
  • Complete full course of treatment as prescribed
  • Follow your doctor's specific instructions carefully

Important Safety Information

Who Should Not Take Semaglutide?

Do not take Semaglutide if you:

  • Are allergic to Semaglutide or any ingredients
  • Have certain medical conditions (discuss with your doctor)
  • Are taking medications that interact with Semaglutide
  • Have severe liver or kidney disease (without dose adjustment)

Drug Interactions

Inform your doctor about all medications you take, including:

  • Prescription medications
  • Over-the-counter drugs
  • Vitamins and supplements
  • Herbal products

Some medications may interact with Semaglutide, affecting its efficacy or increasing side effect risk.

Pregnancy and Breastfeeding

Pregnancy:

  • Discuss risks and benefits with your doctor if pregnant or planning pregnancy
  • May require special monitoring or dose adjustments
  • Some medications should be avoided during pregnancy

Breastfeeding:

  • Consult your doctor about safety while breastfeeding
  • May pass into breast milk
  • Benefits and risks should be carefully considered

Monitoring and Follow-Up

While taking Semaglutide, your doctor may monitor:

  • Effectiveness of treatment (symptom improvement)
  • Side effects or adverse reactions
  • Laboratory values if applicable
  • Blood pressure, heart rate, or other vital signs as appropriate
  • Overall response to therapy

Regular follow-up appointments are important to ensure the medication is working properly and to make any necessary adjustments.

Managing Side Effects

Most side effects are mild and improve with time. Here are strategies for common side effects:

Gastrointestinal Upset

  • Take with food if allowed
  • Stay well hydrated
  • Eat smaller, more frequent meals
  • Report persistent nausea or vomiting

Dizziness

  • Rise slowly from sitting or lying positions
  • Avoid sudden movements
  • Stay hydrated
  • Avoid alcohol
  • Report severe or persistent dizziness

Fatigue

  • Get adequate rest
  • Maintain regular sleep schedule
  • Exercise as tolerated
  • Report excessive tiredness that interferes with daily activities

Lifestyle Considerations

To maximize the benefits of Semaglutide:

  • Follow a healthy, balanced diet
  • Exercise regularly as recommended by your doctor
  • Maintain a healthy weight
  • Avoid alcohol or limit consumption
  • Don't smoke
  • Manage stress through relaxation techniques
  • Get adequate sleep
  • Stay well hydrated
  • Keep all follow-up appointments
  • Take medication consistently as prescribed

When to Contact Your Doctor

Seek immediate medical attention if you experience:

  • Signs of severe allergic reaction (difficulty breathing, severe rash, swelling)
  • Chest pain or rapid heartbeat
  • Severe dizziness or fainting
  • Unusual bleeding or bruising
  • Signs of liver problems (yellowing of skin/eyes, dark urine, severe fatigue)
  • Severe stomach pain
  • Any symptoms that concern you

Contact your doctor for non-emergency issues:

  • Mild to moderate side effects that persist
  • Questions about your medication
  • Concerns about effectiveness
  • New medications prescribed by another doctor
  • Scheduled surgery or dental procedures
  • Planning pregnancy

Storage

Store Semaglutide at room temperature (68-77°F or 20-25°C) away from light, heat, and moisture. Keep in original container. Keep out of reach of children and pets. Do not use past expiration date.

Important Reminders

  • Take exactly as prescribed by your doctor
  • Don't stop suddenly without medical advice
  • Keep all follow-up appointments
  • Report any unusual symptoms
  • Don't share medication with others
  • Store safely away from children
  • Check expiration dates
  • Ask your pharmacist if you have questions

Clinical Benefits

When used appropriately, Semaglutide provides several benefits:

  • Effective management of type 2 diabetes and weight management
  • Improvement in quality of life
  • Reduction in symptoms
  • Prevention of complications
  • Generally well-tolerated when used as directed
  • Backed by clinical research and extensive use

Disclaimer: This information is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your physician or other qualified healthcare provider with any questions about a medical condition or medication.

Frequently Asked Questions

All three contain semaglutide. Ozempic is a weekly injection FDA-approved for type 2 diabetes (and cardiovascular risk reduction in diabetics with established cardiovascular disease). Wegovy is a weekly injection at higher doses approved for chronic weight management and, in 2024, for cardiovascular risk reduction in non-diabetic patients with overweight or obesity and established cardiovascular disease. Rybelsus is the oral tablet form approved for type 2 diabetes.
Stepwise titration over 16 weeks (Wegovy) or 8+ weeks (Ozempic) lets the gastrointestinal system adapt and substantially reduces nausea, vomiting, and diarrhea — the most common reasons people stop GLP-1 therapy. Skipping ahead almost always means worse side effects without faster benefit.
In the STEP trials, average weight loss with Wegovy 2.4 mg weekly plus lifestyle counseling was approximately 14–15 percent of body weight at 68 weeks, compared to about 2.5 percent with placebo plus lifestyle. Individual response varies widely. Patients who do not achieve at least 5 percent weight loss by month 6 are unlikely to gain meaningful benefit from continued therapy at the same dose.
Semaglutide carries an FDA boxed warning for thyroid C-cell tumors based on rodent studies. The clinical relevance to humans remains uncertain, but the medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). Report any neck mass, persistent hoarseness, or difficulty swallowing.
Most patients regain a substantial portion of lost weight within a year of stopping — STEP trial extension data showed roughly two-thirds of weight loss reversed within a year off therapy. Diabetes-related glycemic improvements similarly fade. Sustained results require either continued treatment or substantial, durable lifestyle changes — typically both.
Beyond GI side effects and the thyroid warning, important risks include pancreatitis (stop the drug if severe persistent abdominal pain develops), gallbladder disease (rapid weight loss is a risk factor), diabetic retinopathy worsening in patients with pre-existing retinopathy, acute kidney injury related to severe vomiting or dehydration, and rarely, ileus or gastroparesis. Discuss any persistent abdominal symptoms promptly with your provider.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

  • Is semaglutide the best fit for my goals, and at what dose?
  • How will we measure success — weight loss percentage, A1C, both?
  • Should the doses of my other diabetes medications be adjusted?
  • What dietary and exercise plan supports the medication best?
  • How long do you anticipate I will need to stay on it, and what is the discontinuation plan?

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.